Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Historical Holders from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
LUCD on Nasdaq
Shares outstanding
137,162,201
Price per share
$1.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
35,149,381
Holdings value
$35,503,868
% of all portfolios
0%
Share change
+16,212,809
Value change
+$16,337,033
Average buys %
+0%
Average sells %
-0%
Number of holders
83
Price from insider filings
$1.02
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PAVmed Inc. 28% $39,205,072 38,816,903 PAVmed Inc. 09 Oct 2025
Ayrton Capital LLC 2% $1,404,567 1,200,485 Ayrton Capital LLC 31 Dec 2024
As of 30 Sep 2025, Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) has 83 institutional shareholders filing 13F forms. They hold 35,149,381 shares of 137,162,201 outstanding shares (26%) .

Top 25 institutional shareholders own 25% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 3.3% 4,523,997 +9.6% 0% $4,569,237
MASTERS CAPITAL MANAGEMENT LLC 2.9% 3,999,273 +47% 0.65% $4,039,266
BlackRock, Inc. 2.7% 3,669,292 +1.4% 0% $3,705,985
Two Seas Capital LP 2.2% 3,000,000 0.18% $3,030,000
AWM Investment Company, Inc. 2.2% 2,990,500 0.28% $3,020,405
Ghisallo Capital Management LLC 2.2% 2,960,066 0.1% $2,989,667
Aberdeen Group plc 1.8% 2,500,000 0% $2,525,000
GEODE CAPITAL MANAGEMENT, LLC 1.2% 1,674,173 +6.1% 0% $1,691,131
Alyeska Investment Group, L.P. 1% 1,383,116 +87% 0% $1,396,947
PERKINS CAPITAL MANAGEMENT INC 0.82% 1,127,000 1% $1,138,270
STATE STREET CORP 0.74% 1,017,787 +63% 0% $1,027,965
LUMINUS MANAGEMENT LLC 0.67% 912,805 +15% 0.83% $921,933
WELLS FARGO & COMPANY/MN 0.52% 714,313 +215% 0% $721,456
GOLDMAN SACHS GROUP INC 0.41% 560,154 +81% 0% $565,756
NORTHERN TRUST CORP 0.37% 503,745 -4.8% 0% $508,783
Sunbelt Securities, Inc. 0.28% 383,999 +357% 0.03% $387,839
Lido Advisors, LLC 0.28% 383,082 0% 0% $386,913
FIRST MANHATTAN CO. LLC. 0.24% 323,450 0% 0% $326,685
RENAISSANCE TECHNOLOGIES LLC 0.21% 293,633 +21% 0% $296,569
Bank of New York Mellon Corp 0.15% 205,889 +31% 0% $207,948
XML Financial, LLC 0.13% 178,795 0% 0.01% $180,583
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.13% 174,868 0% 0% $176,617
UBS Group AG 0.11% 145,244 +117% 0% $146,696
LPL Financial LLC 0.1% 141,179 +366% 0% $142,591
BARCLAYS PLC 0.07% 100,276 -16% 0% $101,279

Institutional Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 144 $158 +$158 $1.30 2
2025 Q3 35,149,381 $35,503,868 +$16,337,033 $1.01 83
2025 Q2 18,928,571 $21,732,070 +$10,810,125 $1.15 70
2025 Q1 9,361,696 $13,942,564 +$9,083,705 $1.49 46
2024 Q4 3,301,334 $2,700,118 +$681,674 $0.8187 31
2024 Q3 2,453,404 $1,999,216 +$373,764 $0.8150 27
2024 Q2 1,993,582 $1,635,840 -$61,085 $0.8200 31
2024 Q1 2,069,438 $1,686,991 +$171,402 $0.8099 24
2023 Q4 1,747,190 $2,463,380 -$132,320 $1.41 23
2023 Q3 1,915,159 $2,240,076 +$59,719 $1.17 23
2023 Q2 1,863,743 $2,590,935 +$131,897 $1.39 16
2023 Q1 1,768,504 $2,486,590 -$199,056 $1.40 18
2022 Q4 1,914,916 $2,603,465 -$580,342 $1.36 21
2022 Q3 2,284,579 $3,493,489 -$168,502 $1.53 19
2022 Q2 2,455,369 $5,552,000 -$950,261 $2.26 23
2022 Q1 2,705,630 $9,090,000 -$1,934,644 $3.36 30
2021 Q4 3,306,039 $17,750,000 +$14,788,043 $5.37 34